Rheumatoid arthritis may be associated with a number of pulmonary complications including pleural effusions, rheumatoid lung nodules, fibrosing alveolitis, bronchiectasis, and airways obstruction.' Obliterative bronchiolitis, which occurs in adults most frequently following inhalation of toxic fumes,2 has recently been reported to occur in patients with rheumatoid arthritis,3 possibly following treatment with penicillamine.4
I In this report we describe 2 further cases of obliterative bronchiolitis in patients with rheumatoid disease both of whom had received penicillamine treatment. Table 1 and her flow volume measurements in Table 2 and Fig. 1 . These show severe airways obstruction at low lung volumes with normal lung compliance and a normal Kco. There was no improvement after a bronchodilator. Her penicillamine was stopped and she was started on prednisolone 40 mg daily, which after 14 days produced no improvement. The steroid was subsequently reduced and the patient put on azathioprine 50 mg b.d. Her respiratory function continued to deteriorate until the azathioprine was increased to 150 mg daily. On this higher dose her effort tolerance improved and her lung function studies have stopped deteriorating (Table 2 and Fig. 2 ).
Discussion
These 2 patients with rheumatoid arthritis developed generalised small airways obstruction. The first was diagnosed only at necropsy; the second was diagnosed with appropriate lung function testing. She has been started on azathioprine and her disease appears to be stabilising. Both patients had received penicillamine.
The diagnosis of the condition requires elimination of more common conditions such as multiple pulmonary emboli, large airways obstruction, parenchymal lung disease, and pulmonary oedema. Clinically, rapidly progressing dyspnoea, unproductive cough, basal crepitations, and a very distinctive midinspiratory squeak,3 which was mistaken in our first case for a wheeze, are the most informative features. The duration and activity of the rheumatoid arthritis do not appear to be of any clinical significance. The chest x-ray is usually normal or shows hyperinflation only. However, appropriate lung function tests enable the diagnosis to be made quickly and confidently. These show the characteristic pattern of airways obstruction at low lung volumes, with normal compliance excluding emphysema, and normal or only slightly reduced transfer factor. Transbronchial lung biopsy is usually unhelpful in diagnosing this condition, although it may be necessary to exclude parenchymal disease. Evidence implicating penicillamine as a causal agent in this rare but serious complication of rheumatoid arthritis is conflicting. Of the 12 cases that have previously been reported from various centres 9 received penicillamine.36 Against this must be considered the relative paucity of cases among large numbers of patients treated with this useful drug.7 We recommend that all patients receiving it who develop unexplained respiratory symptoms be carefully examined with obliterative bronchiolitis in mind, and have appropriate lung function tests if necessary.
Obliterative bronchiolitis does not respond to corticosteroids and has an invariably poor, if not fatal outcome, within a few months of its diagnosis. It is of some interest that our second patient has had an improvement in her exercise tolerance since beginning azathioprine and her lung function studies have stabilised.
